Medical University of Innsbruck, Innsbruck, Austria.
Department of Public Health and Epidemiology, University of Cagliari, Cagliari, Italy.
Curr Opin Organ Transplant. 2024 Dec 1;29(6):376-381. doi: 10.1097/MOT.0000000000001177. Epub 2024 Oct 23.
Despite significant advancements in the field of vascularized composite allotransplantation, challenges, particularly regarding the long-term viability and functionality of vascularized composite allotransplantation (VCA) grafts, persist. This paper provides a review of the current literature on the longevity of VCA grafts, focusing on factors influencing graft survival, immunological considerations and clinical outcomes.
Longevity of VCA grafts is influenced by a variety of peri- and postoperative factors including cold ischemia time, human leukocyte antigen matching, environmental exposure, psychosocial factors, adherence, immunosuppression, and complications. Due to the limited number of VCA transplants performed and heterogenous reporting, direct correlation of single factors with VCA outcomes remains inconclusive. Indirect evidence, however, supports their importance. High immunosuppressive burden, frequent occurrence of acute and accumulating cases of chronic rejection remain a significant challenge of the field.
Insights gained from this review aim to inform clinical practice and guide future research endeavors with the goal of ameliorating outcomes after VCA transplantation and facilitate wider use of VCA grafts for restoration of tissue defects.
尽管血管化复合组织同种异体移植领域取得了重大进展,但仍存在挑战,特别是在血管化复合组织同种异体移植(VCA)移植物的长期存活和功能方面。本文综述了关于 VCA 移植物寿命的当前文献,重点介绍了影响移植物存活的因素、免疫学考虑因素和临床结果。
VCA 移植物的寿命受到多种围手术期因素的影响,包括冷缺血时间、人类白细胞抗原匹配、环境暴露、社会心理因素、依从性、免疫抑制和并发症。由于进行的 VCA 移植数量有限且报告方式多样,因此单个因素与 VCA 结果的直接相关性仍不确定。然而,间接证据支持它们的重要性。高免疫抑制负担、频繁发生急性和累积性慢性排斥反应仍然是该领域的重大挑战。
从本次综述中获得的见解旨在为临床实践提供信息,并指导未来的研究工作,以改善 VCA 移植后的结果,并促进更广泛地使用 VCA 移植物来修复组织缺陷。